Effectiveness of the Use of Lightback in Conventional Football Training.

March 24, 2025 updated by: JORGE VELAZQUEZ SAORNIL, Universidad Católica de Ávila

Effectiveness of the Use of Lightback in Conventional Football Training. Randomised Clinical Trial.

Lightback is a patented device that allows instrumental stretching of the gluteal muscles. Football players overload this musculature and this type of device is effective and the cost/benefit ratio is high.

The intention is to carry out a randomised clinical trial to carry out a study on athletes to see the differences between a group of football players with their normal training and a group of football players with their normal training and the application of lightback beforehand.

The variables studied will be sprint speed in 20 and 40m, vertical jump height, hamstring muscle injuries throughout the season, triceps sural injuries throughout the season, internal and external hip ROM, dorsal flexion ankle ROM.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Ávila, Spain, 05005
        • Universidad Católica de Ávila

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Professional football players
  • Age range 18 to 45 years
  • Able to perform physical exertion without discomfort.

Exclusion Criteria:

  • Football players recently injured or in an active recovery phase.
  • Heterometrics
  • Non-collaborators
  • Alteration of sensitivity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lightback group
Use of the lightback device to relax the gluteal musculature.
Device: Lightback group
Use of the patented Lightback device to relax the gluteal musculature and prevent hamstring injuries.
Active Comparator: Conventional group
Conventional treatment to relax the gluteal musculature and prevent hamstring injuries.
Other: Conventional treatment
Conventional treatment to relax the gluteal musculature and prevent hamstring injuries.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion
Time Frame: 5 weeks
Measurement of hip joint range and ankle dorsiflexion measured with goniometer
5 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sprint
Time Frame: 5 weeks
Measurement of speed over 20 and 40 metres using approved devices
5 weeks
Vertical jump height
Time Frame: 5 weeks
Measurement of height (metres) using approved devices
5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad Católica de Ávila

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Actual)

November 30, 2024

Study Completion (Actual)

March 24, 2025

Study Registration Dates

First Submitted

June 29, 2024

First Submitted That Met QC Criteria

June 29, 2024

First Posted (Actual)

July 8, 2024

Study Record Updates

Last Update Posted (Actual)

March 27, 2025

Last Update Submitted That Met QC Criteria

March 24, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 290624

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Injury; Hip

Clinical Trials on Lightback group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe